NIOX Group Plc Stock | Analysis for March 2026, Price & Rating

NIOX Group Plc

AIM:NIOX

£ 0,60

+ £0,01 (1,69%)

0,60 £

+£0,01 (1,69%)

End-of-day quote: 03/25/2026

NIOX Group Plc Stock Value

The analyst rating for AIM:NIOX is currently Buy.

Buy

NIOX Group Plc Company Info

EPS Growth 5Y

17,98%

Market Cap

£0,25 B

Long-Term Debt

£0,11 B

Annual earnings

N/A

Dividend

£0,01

Dividend Yield

2,12%

Founded

2006

Industry

Health Care

Country

United Kingdom

Website

NIOX Group Plc

ISIN Number

GB00BJVD3B28

Website

http://investors.niox.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

£0,82

36.67%

Last Update: 03/22/2026

Analysts: 5

Highest Price Target £0,88

Average Price Target £0,82

Lowest Price Target £0,79

In the last five quarters, NIOX Group Plc’s Price Target has risen from £0,80 to £0,83 - a 3,75% increase. Four analysts predict that NIOX Group Plc’s share price will increase in the coming year, reaching £0,82. This would represent an increase of 36,67%.

Top growth stocks in the health care sector (5Y.)

What does NIOX Group Plc do?

NIOX Group PLC operates as a medical technology company specializing in respiratory health diagnostics. Business Segments The company operates primarily within the respiratory health diagnostics sector, encompassing various business segments that contribute strategically to its overarching vision. Business Strategy The company’s business strategy is defined by a commitment to innovation and excellence in respiratory diagnostics. A core component of the strategy is a focus on research and dev...

NIOX Group PLC operates as a medical technology company specializing in respiratory health diagnostics.

Business Segments

The company operates primarily within the respiratory health diagnostics sector, encompassing various business segments that contribute strategically to its overarching vision.

Business Strategy

The company’s business strategy is defined by a commitment to innovation and excellence in respiratory diagnostics. A core component of the strategy is a focus on research and development, allocating significant resources to enhance existing products and create new solutions that meet evolving healthcare needs.

Products and Services

The company specializes in high-quality medical diagnostics products that center around the measurement of FeNO. The flagship product, the NIOX device, is designed to provide healthcare professionals with rapid and reliable readings of airway inflammation. This aids in making informed decisions about the management of asthma and COPD.

The company also provides a range of consumables, such as single-use testing kits, which enhance the functionality of the NIOX device. These consumables ensure accurate measurements during each test, fostering continuity in patient care.

In addition, the company offers software solutions that accompany its hardware, providing data management capabilities for healthcare providers. The integration of technology within diagnostics facilitates better patient tracking and record-keeping, contributing to streamlined clinic operations.

Geographical Markets Served

The company serves a diverse range of geographical markets, allowing for expansive reach and impact across various regions. The company operates in North America, Europe, and Asia-Pacific, each being critical to its overall business strategy. The North American market remains a core area of focus due to the high prevalence of respiratory diseases and robust healthcare infrastructure.

The company's strategy to enter and expand within Asia-Pacific is bolstered by increasing awareness and demand for advanced diagnostic technologies in respiratory health. The company is actively pursuing opportunities within this market through tailored products and partnerships with local health authorities.

Additionally, the company announced the strategic decommissioning of certain product lines following a thorough market analysis, focusing its resources on the most prosperous segments. This decision reflects an agile approach to business management, ensuring that the company's focus remains aligned with market needs.

Customers

The company serves a wide range of customers that include healthcare professionals in hospitals, clinics, and specialized respiratory health centers. The primary categories of customers consist of physicians, pulmonologists, and general practitioners who utilize NIOX technology in diagnosing and managing respiratory conditions.

Modes of Sales and Marketing

The company employs a multi-faceted marketing strategy to engage with healthcare professionals and institutions. Key elements of the marketing strategy include direct sales efforts, participation in medical conferences, and partnerships with key opinion leaders in the field of respiratory health.

Distribution Channels

Distribution channels are strategically developed to align with the needs of healthcare providers, ensuring that the company’s products are readily available in both urban and rural settings. The company utilizes online platforms for product education, offering supporting documentation and training which enhances the buying process for healthcare providers.

History

The company was founded in 2006. The company was incorporated in 2006. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc.

New support ticket

Explore

NIOX Group Plc Stock Value

NIOX Group Plc Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does NIOX Group Plc do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

NIOX Group Plc Stock Value

NIOX Group Plc Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does NIOX Group Plc do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.